United States ex rel. Deborah Sheldon v. Allergan Sales, LLC

  1. January 26, 2022

    4th Circ. Backs Toss Of FCA Medicaid Suit Against Allergan

    A split Fourth Circuit panel has refused to revive a False Claims Act suit alleging an Allergan unit fraudulently reported drug prices to Medicaid and cost the federal government at least $680 million, finding that the company didn't "knowingly" make false claims.